Management of the Hepatic Lymph Nodes during Resection of Liver Metastases from Colorectal Cancer: A Systematic Review

Table 2

Survival in each study^*.

Study	Node-positive				Node-negative
	Total	One-year survival	Three-year survival	Five-year survival	Total	One-year survival	Three-year survival	Five-year survival
Nakamura et al. [28]	6	—	2 (33.3%)	—	16	—	10 (62.5%)	—
Yasui et al. [35]	8	—	2 (25%)	0 (0%)	56	—	33 (58.9%)	18 (32.1%)
Beckhurts et al. [8]	35	—	1 (2.9%)	0 (0%)	91	—	44 (48.4%)	20 (22.0%)
Kokudo et al. [18]	7	6 (85.7%)	2 (28.6%)	0 (0%)	87	84 (96.6%)	57 (65.5%)	47 (54.0%)
Ambiru et al. [7]	8	—	1 (12.5%)	1 (12.5%)	141	—	63 (44.7%)	38 (27.0%)
Harms et al. [29]	39	—	1 (2.6%)	0 (0%)	116	—	52 (44.8%)	24 (20.7%)
Sanchez-Cespedes et al. [37]	8	2 (25%)	0 (0%)	—	7	7	2/4^† (50%)	—
Jaeck et al. [16, 25]	17	4 (23.5%)	2 (11.8%)	0 (0%)	143	135 (94.4%)	89 (62.2%)	67 (46.9%)
Laurent et al. [15]	23	16 (69.6%)	6 (26.1%)	1 (4.3%)	133	117 (88%)	74 (55.6%)	32 (24.1%)
Total	151	28/55 (50.9%)	17/151 (11.3%)	2/137 (1.5%)	790	343/370 (92.7%)	424/787 (53.9%)	246/767 (32.1%)

^*Percentages in brackets; ^†The follow-up for the other 3 patients was <3 years